Kroese, Mark <br/><br/>
HER2 status in breast cancer--an example of pharmacogenetic testing.  [electronic resource] 

 -  Journal of the Royal Society of Medicine  Jul 2007 
 - 326-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0141-0768 
<br/><br/><label>Standard No.: </label>10.1177/014107680710000715  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Antineoplastic Agents--therapeutic use<br/>Breast Neoplasms--drug therapy<br/>Female<br/>Genes, erbB-2<br/>Humans<br/>Immunohistochemistry--methods<br/>In Situ Hybridization, Fluorescence--methods<br/>Pharmacogenetics<br/>Practice Guidelines as Topic<br/>Predictive Value of Tests<br/>Receptor, ErbB-2--genetics<br/>Trastuzumab